Skip to main content
Curtis Lachowiez, MD, Internal Medicine, Portland, OR

Curtis Andrew Lachowiez MD

Hematology/Oncology


Physician

Join to View Full Profile
  • 3181 SW Sam Jackson Park RdPortland, OR 97239

  • Phone+1 503-494-5058

  • Fax+1 503-494-5065

Dr. Lachowiez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 2015

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2017 - 2025
  • TX State Medical License
    TX State Medical License 2020 - 2024
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society

Publications & Presentations

PubMed

Press Mentions

  • ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2024
    ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2024October 24th, 2024
  • ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in First-Line Acute Myeloid Leukemia
    ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in First-Line Acute Myeloid LeukemiaSeptember 9th, 2024
  • Determining the Optimal Frontline Treatment of AML
    Determining the Optimal Frontline Treatment of AMLDecember 6th, 2021
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: